Neuronal death in pneumococcal meningitis is triggered by pneumolysin and RrgA interactions with β-actin

Mahebali Tabusi1,2, Sigrun Thorsdottir1,2, Maria Lysandrou1,2

  • 1Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, BioClinicum J7:20, Stockholm, Sweden.

Plos Pathogens
|March 24, 2021
PubMed

Insights

Streptococcus pneumoniae interacts with neuronal β-actin via RrgA and pneumolysin (Ply), causing neuronal death. Blocking β-actin with antibodies prevents this damage, explaining neurological issues after meningitis.

Area of Science:

  • Neuroscience
  • Microbiology
  • Cell Biology

Background:

  • Bacterial meningitis, particularly from Streptococcus pneumoniae, causes significant neuronal damage.
  • Mechanisms underlying pneumococcal interaction with neurons leading to cell death remain unclear.
  • Neurological sequelae in meningitis survivors suggest persistent neuronal injury.

Purpose of the Study:

  • To elucidate the mechanisms of Streptococcus pneumoniae interaction with neurons.
  • To identify bacterial factors and host targets involved in pneumococcal-induced neuronal death.
  • To explore therapeutic strategies targeting bacterial-neuronal interactions.

Main Methods:

  • Utilized human primary neurons and a bacteremia-derived meningitis mouse model.
  • Employed pull-down assays, mass spectrometry, and STED super-resolution microscopy.
  • Investigated interactions using purified bacterial proteins and antibodies.

Main Results:

  • Pneumococci bind to neuronal β-actin via RrgA and pneumolysin (Ply).
  • Ply facilitates RrgA binding by altering the neuronal membrane and exposing β-actin.
  • Infection leads to actin cytoskeleton disassembly, intracellular Ca2+ increase, and neuronal death.
  • Antibodies against β-actin inhibited pneumococcal-induced neuronal death.

Conclusions:

  • Streptococcus pneumoniae directly interacts with neuronal β-actin, mediated by RrgA and Ply.
  • This interaction promotes bacterial adhesion, invasion, and neuronal cell death.
  • Targeting the β-actin-pneumococcus interaction offers a potential strategy to prevent meningitis-related neurological damage.